Promega Introduces MethylEdge™ Bisulfite Conversion System for DNA Methylation Analysis

Complete, ready-to-use solution for rapid, robust conversion with more intact DNA

MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation announced today that it has launched MethylEdge™ Bisulfite Conversion System. The system offers an efficient method for rapidly performing bisulfite conversion and DNA clean-up within two hours, while maintaining DNA integrity to provide more intact, converted DNA for a variety of sensitive applications.

MethylEdge requires only small amounts of input genomic DNA (100pg-2µg). Using optimized conversion reagents, clean-up and recovery methods, the system converts DNA at ≥90% efficiency with minimal fragmentation. The resulting DNA is suitable for use in downstream applications such as PCR, array, or sequencing assays.

The kit includes all reagents necessary to perform 50 bisulfite conversion reactions. All MethylEdge reagents can be stored at room temperature and require minimal up-front preparation. Control DNAs are also available separately and can be used as standards in both the conversion reaction and post-conversion analysis.

The Promega MethylEdge Bisulfite Conversion System complements Promega nucleic acid purification kits for a wide variety of sample types and throughput levels, quantitation chemistries for both pre- and post-conversion, and Promega amplification technologies for detection, providing a quality workflow solution to DNA methylation sample preparation.

For more information please visit: www.promega.com/methylation

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.